India Globalization Capital, Inc. (IGC)

igcIndia Globalization Capital, Inc operates in several locations around the world to acquire, incubate, finance, and grow companies in various industries. Through its subsidiaries, it has businesses in India, Inner Mongolia, China, Hong Kong, and the United States. Its business lines include iron ore processing, electronic components trading, clean energy, equipment leasing, and vertical farming, and it has entered the marijuana industry as well.

The company’s foray into the legal cannabis industry involves its vertical farming projects in the US. Currently, it is planning to build indoor vertical farms designed to produce organic green vegetables, and eventually, legal marijuana. Also part of the company’s strategy are creating a portfolio of cannabis and hemp-based patents, developing FDA-approved drugs based on cannabinoids, and establishing a cannabis R&D laboratory.

More recently, the multi-national company acquired Midtown Partners & Co, LLC, a New York-based licensed broker-dealer, to expand its marijuana strategy. With Midtown as its subsidiary, IGC will offer capital-raising platforms and broker-dealer services to cannabis businesses. One of the major platforms it plans to build is a crowdfunding site for small to midsize enterprises. Other services will include investment banking and equity research.

The legal marijuana industry is only one of the areas where IGC intends to expand. To minimize its dependence on its iron ore business, its diversification strategy aims for growth in clean technology, solar energy, and specialty pharmaceuticals as well.

India Globalization Capital was incorporated in Maryland in 2005. It now trades in the NYSE MKT with the symbol IGC, and a market cap of USD 8.69 M.

Among the top management executives in the company are Ram Mukunda, CEO, President, and Director; Daniel Ngai, Principal Financial and Accounting Officer; and Belur Ram Kishan, Sunny Tsang, and Amit Dutta, Managing Directors.

Yahoo! Finance: IGC News

Latest Financial News for IGC

IGC Provides Corporate Updates

India Globalization Capital, Inc. (IGC) announces today that, as of Wednesday, March 27, 2019, Hyalolex™, the Company’s cannabinoid-based, non-FDA approved product designed to assist in helping improve the lives of patients suffering from Alzheimer’s disease, will be available for purchase in select dispensaries in San Juan, Puerto Rico. The Company will host a doctor-patient education conference on Saturday, March 30, 2019, from 9:00 a.m. to 5:00 p.m., in San Juan, featuring several speakers. On January 24, 2019, the Company terminated its Licensing Agreement with DaMa Pharmaceutical, LLC, with a 90-day notice period, with the termination effective April 24, 2019, and the parties were unable to negotiate a replacement agreement.

Top Cannabis Plays-THC Therapeutics, Inc

HENDERSON, NV / ACCESSWIRE / March 12, 2019 / Year to date, the Global Cannabis Stock Index is up almost 50% in less than three months. It's safe to say investors are bullish on the cannabis. Here are ...

Four Marijuana Stocks Green and Ready for the Picking

Global Consortium Inc (OTC:GCGX), India Globalization Capital Inc (NYSE American: IGC), Aphria Inc (NYSE: APHA, TSX: APHA), and Intellipharmaceutics International Inc (NASDAQ:IPCI) are 4 pot stocks worth looking into this week. Global Consortium Inc (OTC:GCGX) is a company that you might not have heard of but could benefit from checking out as we continue in this new year. Global Consortium Inc (OTC:GCGX) has made it a point to build a corporate framework to support its endeavors, recent of which have included building a "Cannabis Mall." According to reports, the project, once completed, will house manufacturing, distribution, delivery, retail, testing, and cultivation all under one 64,000 sq. ft building.

IGC Announces Successful Appeal of Delisting Proceedings and Imminent Relisting on NYSE American

PINK: IGCC) announced today that it has successfully challenged NYSE American’s decision to delist the common stock of the Company from trading on the Exchange under the Exchange’s appeal procedures. In a written decision issued on February 20, 2019, a review panel of the Exchange unanimously ruled to set aside the Exchange’s October 29, 2018 decision to delist the Company’s common stock, finding that the Company has not discontinued the business it conducted at the time it was first listed on the Exchange.

FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against India Globalization Capital, Inc. (IGC) & Lead Plaintiff Deadline - January 2, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against India Globalization Capital, Inc. ("India Globalization" or the "Company") (NYSE: IGC) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired India Globalization securities between October 25, 2017 and October 29, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: